We searched MEDLINE between Dec 1, 2017, and Dec 19, 2017, with no language restrictions. We used the search terms “melanoma” in combination with specific terms covering the different steps of diagnosis and treatment as appropriate. We largely selected publications in the past 5 years, but did not exclude commonly referenced and highly regarded older publications. We also searched the reference lists of articles identified by this search strategy and selected those we judged relevant. Review
SeminarMelanoma
Section snippets
Incidence, mortality, and survival
Worldwide, about 232 100 (1·7%) cases of all newly diagnosed primary malignant cancers (excluding non-melanoma skin cancer) are cases of cutaneous melanoma, and about 55 500 cancer deaths (0·7% of all cancer deaths) are due to cutaneous melanoma annually. The incidence and mortality rates of cutaneous melanoma differ widely by country. In 2012, the age-standardised (world standard population) incidence of cutaneous melanoma ranged from 0·2 per 100 000 person-years in southeast Asia to 7·7 per
Mechanisms and pathophysiology
The malignant transformation of melanocytes into metastatic melanoma is the result of a process that requires a complex interaction between exogenous and endogenous triggers as well as tumour-intrinsic and immune-related factors. Although melanocytes only rarely divide (less than twice per year),16 the proliferative index steadily increases as melanocytic neoplasms sequentially evolve, a process accompanied by a constant increase of point mutations and copy-number alterations.17 Cross-cancer
Histopathological classification
Melanoma is diagnosed histopathologically, with subsequent treatment decisions being based on histological classification and risk calculation. Classification is established with tumour thickness (T stage; Breslow staging),28 lymph node involvement (N stage), and presence of metastasis (M stage). The majority of melanomas are diagnosed before lymph node or distant metastases occur (N0 and M0 stage).29, 30 According to Breslow,28 the most crucial criterion for assessing prognosis and further
Screening and melanoma surveillance
People at an increased risk for melanoma (ie, those who have a fair skin type, multiple atypical moles, or a family history of melanoma) should be screened at regular intervals. The screening populations and methods differ between countries, and often no exact guidelines exist. Generally, screening for melanoma includes a total body skin examination supported by dermoscopy or other imaging techniques, with both examinations performed by an experienced physician. Screening is usually not
Primary tumour: surgical excision and lymph node biopsy
The primary treatment of localised disease (primary tumours) consists of wide local excision with different safety margins, depending on the Breslow22 thickness of the melanoma. Usually, 0·5 cm margins are recommended for in-situ melanomas, 1 cm margins for tumours with a thickness of up to 2 mm, and 2 cm margins for tumours thicker than 2 mm. Several studies analysed narrow versus wide margins, and although they found a reduction in local recurrences for wide margins, they did not show any
Conclusion
Prevention, early detection, and the arrival of effective adjuvant treatment strategies in stage-3 melanoma will increase overall survival and cure rates for patients with melanoma. Using PD-1-based treatment algorithms and targeted agents in BRAFv600-mutant melanoma, 5-year overall survival rates for metastatic melanoma have increased substantially from less than 10% to up to 40–50% today in countries that have access to these innovations.145 Patients with high tumour burden, brain metastasis,
Search strategy and selection criteria
References (146)
- et al.
The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031
J Invest Dermatol
(2016) - et al.
Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study
Eur J Cancer
(2015) - et al.
Reviews on sun exposure and artificial light and melanoma
Prog Biophys Mol Biol
(2011) - et al.
Melanoma epidemiology and public health
Dermatol Clin
(2009) - et al.
Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: a perspective on Fears et al. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. American Journal of Epidemiology 1977; 105: 420–427
Cancer Epidemiol
(2017) - et al.
A landscape of driver mutations in melanoma
Cell
(2012) - et al.
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression
Cell Rep
(2017) - et al.
Melanoma-induced immunosuppression and its neutralization
Semin Cancer Biol
(2012) - et al.
Eighth American Joint Committee on Cancer (AJCC) melanoma classification: let us reconsider stage III
Eur J Cancer
(2018) - et al.
Genetic alterations in primary acral melanoma and acral melanocytic nevus in Korea: common mutated genes show distinct cytomorphological features
J Invest Dermatol
(2018)